Company intelligence / Profile preview

Libo Pharma Corp.

Taiwan Province, China [Taiwan]libopharma.com ↗

Ownership: Public · 7888
Employees: ~50
Development stage: Phase 1

Overview

Libo Pharma Corp. is a clinical-stage biopharmaceutical company operating under a virtual/federated business model. It focuses on accelerating the development of novel therapeutics for unmet medical needs in oncology, hematology, immune disorders, and regenerative medicine. Its lead disclosed asset is a recombinant human interleukin‑12 targeting IL‑12R for cutaneous T-cell lymphoma at the preclinical stage. The company emphasizes stealth mode operations to protect early-stage assets and frequently partners with other pharmaceutical companies for co-development.[1][2][3][4][5]

Therapeutic areas: OncologyImmunologyNephrology
Modalities: Protein therapeutics (e.g., recombinant human interleukin)ImmunomodulatorsAntibody-drug conjugates (ADCs)
Industry: Biotech

Drug pipeline

1 asset

edodekin alfa

Unknown

Partnerships

Engages in partnerships with pharmaceutical companies for co-development of assets ("Drug Discovery Alliance")[4]

Beyond the preview

Go deeper on Libo Pharma Corp..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Libo Pharma Corp..

Explore the full profile